Notes
2017 Canadian dollars
2017 Canadian dollars
Reference
Elliot J, et al. Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis. PharmacoEconomics : 15 May 2018. Available from: URL: https://doi.org/10.1007/s40273-018-0669-7
Rights and permissions
About this article
Cite this article
Adjunctive stiripentol not cost effective in Canada. PharmacoEcon Outcomes News 804, 5 (2018). https://doi.org/10.1007/s40274-018-4969-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4969-0